Reduced-dose cyclophosphamide in combination with fludarabine and anti-thymocyte globulin as a conditioning regimen for allogeneic hematopoietic stem cell transplantation for aplastic anemia

被引:2
|
作者
Kohashi, Sumiko [1 ]
Mori, Takehiko [1 ]
Hashida, Risa [1 ]
Kato, Jun [1 ]
Saburi, Masuho [1 ]
Kikuchi, Taku [1 ]
Koda, Yuya [1 ]
Toyama, Takaaki [1 ]
Yamane, Yusuke [1 ]
Yamanaka, Satomi [1 ]
Okamoto, Shinichiro [1 ]
机构
[1] Keio Univ, Sch Med, Dept Med, Div Hematol,Shinjuku Ku, Tokyo 1608582, Japan
关键词
ALTERNATIVE DONOR TRANSPLANTS; TOTAL-BODY IRRADIATION; SAA WORKING PARTY; ALEMTUZUMAB;
D O I
10.1007/s12185-014-1697-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:102 / 105
页数:4
相关论文
共 50 条
  • [31] Anti-thymocyte globulin substantiated by low dose cyclophosphamide but not irradiation provides sufficient conditioning for hematopoietic progenitor cells transplantation in Fanconi anemia.
    Lange, A
    Tomaszewska, B
    Dlubek, D
    Lange, J
    Sulicz, K
    BLOOD, 1998, 92 (10) : 352B - 352B
  • [32] Alternative donor transplants for aplastic anemia: unmanipulated bone marrow following conditioning with fludarabine (FLU) cyclophosphamide (CY) and anti-thymocyte globulin (ATG)
    Bacigalupo, A
    Van Lint, MT
    Lamparelli, T
    Gualandi, F
    Occhini, D
    Mordini, N
    Barisso, G
    Bregante, S
    Raiola, AM
    BONE MARROW TRANSPLANTATION, 1999, 23 : S70 - S70
  • [33] Feasibility of salvage cord blood transplantation using a fludarabine, melphalan, and low-dose anti-thymocyte globulin conditioning regimen
    Takumi Hoshino
    Satoru Takada
    Nahoko Hatsumi
    Toru Sakura
    International Journal of Hematology, 2019, 109 : 463 - 469
  • [34] Reduced-Intensity Busulfan or TBI/Cyclophosphamide/Fludarabine-Based Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Children with Acquired Severe Aplastic Anemia
    Sun, R. -J.
    Wu, T.
    Xiong, M.
    Wei, Z. -J.
    Zhao, Y. -L.
    Cao, X. -Y.
    Liu, D. -Y.
    Lu, Y.
    Zhang, J. -P.
    Ji, S. -Q.
    Lu, D. -P.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S439 - S439
  • [35] Feasibility of salvage cord blood transplantation using a fludarabine, melphalan, and low-dose anti-thymocyte globulin conditioning regimen
    Hoshino, Takumi
    Takada, Satoru
    Hatsumi, Nahoko
    Sakura, Toru
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (04) : 463 - 469
  • [36] Cyclophosphamide (80MG/KG), fludarabine, and antithymocyte globulin as preparative regimen for hematopoietic stem cell transplantation in children with severe aplastic anemia
    Essa, Mohammed
    Basher, Enas
    Abujoub, Rodaina
    Al Harbi, Talal
    Al Jamaan, Khalid
    Al Omari, Ali
    Al Sudairy, Reem
    Al Sultan, Abdulrahman
    BONE MARROW TRANSPLANTATION, 2019, 54 : 546 - 546
  • [37] Treosulfan and fludarabine:: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation
    Casper, J
    Knauf, W
    Kiefer, T
    Wolff, D
    Steiner, B
    Hammer, U
    Wegener, R
    Kleine, HD
    Wilhelm, S
    Knopp, A
    Hartung, G
    Dölken, G
    Freund, M
    BLOOD, 2004, 103 (02) : 725 - 731
  • [38] Fludarabine-Based Conditioning Chemotherapy for Allogeneic Hematopoietic Stem Cell Transplantation in Acquired Severe Aplastic Anemia
    Al-Zahrani, Hazzaa
    Nassar, Amr
    Al-Mohareb, Fahad
    Al-Sharif, Fahad
    Mohamed, Said
    Al-Anazi, Khalid
    Patel, Moosa
    Rasheed, Walid
    Saleh, Abu Jafar Mohammed
    Bakr, Mahmoud
    Ahmed, Shad
    Ibrahim, Khalid
    Hussain, Fazal
    Elkum, Naser
    Elhassan, Tusneem
    Nurgat, Zubeir
    Chaudhri, Naeem
    Aljurf, Mahmoud
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (05) : 717 - 722
  • [39] Fludarabine-based reduced intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia and fungal infections
    George, Biju
    Mathews, Vikram
    Viswabandya, Auro
    Srivastava, Alok
    Chandy, Mammen
    CLINICAL TRANSPLANTATION, 2009, 23 (02) : 228 - 232
  • [40] Excellent results in the treatment of severe aplastic anemia (SAA) using cyclophosphamide (CY) and anti-thymocyte globulin (ATG) as the preparative regimen in allogeneic bone marrow transplantation (BMT).
    Ririe, D
    Shaughnessy, P
    Moore, R
    Ornstein, D
    BLOOD, 1999, 94 (10) : 386B - 386B